1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

New Drug Approved To Treat Deadly Skin Cancer

The Food and Drug Administration has approved a new drug to treat advanced melanoma, a deadly form of skin cancer.

 
PRLog - Aug. 18, 2011 - The Food and Drug Administration (FDA) has announced the approval of a new drug to treat advanced melanoma, a deadly form of skin cancer.

According to the anniouncement made in Washington, the drug named Zelboraf, was approved for patients with metastatic melanoma, the most life-threatening form of skin cancer and one form that cannot be removed with surgery.

According to scientists, the drug is the latest in a new generation of cancer-fighting drugs specifically medically tailored to attack genetic vulnerabilities of malignancies.  The FDA explained that Zelboraf was approved only for tumors with a specific genetic mutation. The drug was approved with a test that can determine if a patient’s cancer has this particular mutation.

The research testing and findings found that the mutation which produces a version of a protein that is normally involved in regulating cell growth is mutated in about half of patients with advanced melanoma. The report concluded that Zelboraf inhibits the activity of the mutated protein.

Zelboraf, which is marketed by Genentech of San Francisco.  The medication was reviewed under the FDA’s priority review program, which enables the agency to approve drugs quickly.

In a study involving 675 patients with late-stage melanoma with the mutation, 77 percent of those who received Zelboraf were still living, while only 64 percent of those who received a standard chemotherapy drug known as dacarbazine survived eight months, the FDA said.

Melanoma is the leading cause of death from skin disease. About 68,130 new cases of melanoma are diagnosed and about 8,700 people die from the disease each year in the United States according to Jesse Slome, executive director of the American Association for Critical Illness Insurance http://www.criticalillnessinsuranceinfo.org which tracks health news related to cancer and heart disease.

Individuals interested in receiving a cost quote for critical illness insurance from a designated American Association for Critical Illness Insurance professional can complete the organization's free quote request form accessible at http://www.criticalillnessinsuranceinfo.org/free-quote/ or by calling the Association's offices.

# # #

The American Association for Critical Illness Insurance http://www.criticalillnessinsuranceinfo.org is a national trade organization. Get info and costs at their Consumer Information Center: http://www.criticalillnessinsuranceinfo.org/learning-center/

--- End ---

Click to Share

Contact Email:
***@aacii.org Email Verified
Source:American Association for Critical Illness Insuranc
Location:United States
Industry:Health, Medical, Consumer
Tags:cancer, skin cancer, critical illness insurance, cancer insurance, critical illness insurance cost, Health, slome, study
Shortcut:prlog.org/11628624
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share